Case number 3:18-cv-14225
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. CIPLA LTD. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 15, 2019 | 21 | Order (7) Docket Text: ORDER CONSOLIDATING CASES FOR ALL PURPOSES. Civil Action No. 18-13635 shall be the Lead Case and effective upon entry of this order, all filings in the Consolidated Actions are to be made only in Civil Action No. 18-13635. Signed by Judge Peter G. Sheridan on 4/15/2019. (mmh) |
| Apr 15, 2019 | N/A | Terminated Case (0) Docket Text: ***Civil Case Administratively Terminated. (mmh) |
| Mar 21, 2019 | N/A | Pretrial Conference - Initial (0) Docket Text: Text Minute Entry for proceedings held before Magistrate Judge Lois H. Goodman: Initial Pretrial Conference held on 3/21/2019 via Conference Call. (if, ) |
| Mar 5, 2019 | 20 | Answer to Counterclaim (10) |
| Mar 5, 2019 | 20 | Main Document (10) Docket Text: ANSWER to Counterclaim by DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC. (Attachments: # (1) Certificate of Service)(DENI, WILLIAM) |
| Mar 5, 2019 | 20 | Certificate of Service (2) |
| Mar 5, 2019 | N/A | Notice of Pro Hac Vice counsel added (0) Docket Text: Pro Hac Vice counsel, NICHOLAS A. GEIGER and STEVEN M. COYLE, have been added to receive Notices of Electronic Filing. Pursuant to L.Civ.R. 101.1, only local counsel are entitled to sign and file papers, enter appearances and receive payments on judgments, decrees or orders. (mmh) |
| Mar 4, 2019 | 19 | Notice of Pro Hac Vice to Receive NEF (3) Docket Text: Notice of Request by Pro Hac Vice Steven M. Coyle to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number 0312-9466050.) (COHEN, JEFFREY) |
| Mar 4, 2019 | 18 | Notice of Pro Hac Vice to Receive NEF (3) Docket Text: Notice of Request by Pro Hac Vice Nicholas A. Geiger to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number 0312-9466025.) (COHEN, JEFFREY) |
| Mar 1, 2019 | 17 | Order (4) Docket Text: CONSENT ORDER granting Pro Hac Vice admission of Steven M. Coyle, Esq. and Nicholas A. Geiger, Esq. Signed by Magistrate Judge Lois H. Goodman on 3/01/2019. (jem) |
| Feb 22, 2019 | 16 | Order (5) Docket Text: ORDER SCHEDULING CONFERENCE. Scheduling Conference set for 3/21/2019 10:00 AM in Trenton - Courtroom 7E before Magistrate Judge Lois H. Goodman. Signed by Magistrate Judge Lois H. Goodman on 2/22/2019. (mmh) |
| Feb 20, 2019 | N/A | Update Answer Due Deadline (0) Docket Text: Clerk`s Text Order - The document [15] Application for Clerk's Order to Ext Answer/Proposed Order, submitted by VALEANT PHARMACEUTICALS NORTH AMERICA LLC, VALEANT PHARMACEUTICALS IRELAND LTD., DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD. has been GRANTED. The answer due date has been set for 3/5/2019. (mmh) |
| Feb 19, 2019 | 15 | Application for Clerk's Order to Ext Answer/Proposed Order (2) Docket Text: Application and Proposed Order for Clerk's Order to extend time to answer as to Plaintiffs Valeant Pharmaceuticals North America LLC, Valeant Pharmaceuticals Ireland Ltd., Dow Pharmaceutical Sciences, Inc., and Kaken Pharmaceutical Co., Ltd... (DENI, WILLIAM) |
| Jan 28, 2019 | 11 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by JEFFREY A. COHEN on behalf of CIPLA LTD., CIPLA USA INC. (COHEN, JEFFREY) |
| Jan 28, 2019 | 12 | Corporate Disclosure Statement (aty) (3) Docket Text: Corporate Disclosure Statement by CIPLA LTD. identifying NONE as Corporate Parent.. (COHEN, JEFFREY) |
| Jan 28, 2019 | 13 | Corporate Disclosure Statement (aty) (3) Docket Text: Corporate Disclosure Statement by CIPLA USA INC.. (COHEN, JEFFREY) |
| Jan 28, 2019 | 14 | Answer to Complaint (26) Docket Text: ANSWER to Complaint , COUNTERCLAIM against DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC by CIPLA USA INC., CIPLA LTD..(COHEN, JEFFREY) |
| Dec 18, 2018 | 10 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by JUSTIN JAMES HASFORD on behalf of KAKEN PHARMACEUTICAL CO., LTD. (HASFORD, JUSTIN) |
| Dec 11, 2018 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by VALEANT PHARMACEUTICALS NORTH AMERICA LLC, KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD.. CIPLA LTD. waiver sent on 11/28/2018, answer due 2/26/2019. (LOWER, J.) |
| Dec 11, 2018 | 9 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by VALEANT PHARMACEUTICALS NORTH AMERICA LLC, KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD.. CIPLA USA INC. waiver sent on 11/28/2018, answer due 1/28/2019. (LOWER, J.) |
| Dec 5, 2018 | 7 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by J. BRUGH LOWER on behalf of DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC (LOWER, J.) |
| Sep 25, 2018 | N/A | Add and Terminate Judges (0) Docket Text: Judge Peter G. Sheridan and Magistrate Judge Lois H. Goodman added. (jmh) |
| Sep 25, 2018 | 4 | AO120 Patent/Trademark Form (1) Docket Text: AO120 Patent Form filed. (jmh) |
| Sep 25, 2018 | 5 | AO120 Patent/Trademark Form (1) Docket Text: AO120 Patent Form filed. (jmh) |
| Sep 25, 2018 | 6 | Summons Issued (2) Docket Text: SUMMONS ISSUED as to CIPLA LTD., CIPLA USA INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (jmh) |
| Sep 24, 2018 | 1 | Complaint (25) |
| Sep 24, 2018 | 3 | Corporate Disclosure Statement (aty) (1) Docket Text: Corporate Disclosure Statement by KAKEN PHARMACEUTICAL CO., LTD.. (DENI, WILLIAM) |
| Sep 24, 2018 | 2 | Corporate Disclosure Statement (aty) (1) Docket Text: Corporate Disclosure Statement by DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC identifying Bausch Health Companies Inc. as Corporate Parent.. (DENI, WILLIAM) |
| Sep 24, 2018 | 1 | L. Civ. R. 11.2 Certification (2) |
| Sep 24, 2018 | 1 | Civil Cover Sheet (3) |
| Sep 24, 2018 | 1 | Exhibit H (11) |
| Sep 24, 2018 | 1 | Exhibit G (17) |
| Sep 24, 2018 | 1 | Exhibit F (14) |
| Sep 24, 2018 | 1 | Exhibit E (11) |
| Sep 24, 2018 | 1 | Exhibit D (17) |
| Sep 24, 2018 | 1 | Exhibit C (17) |
| Sep 24, 2018 | 1 | Exhibit B (16) |
| Sep 24, 2018 | 1 | Main Document (25) Docket Text: COMPLAINT against CIPLA LTD., CIPLA USA INC. ( Filing and Admin fee $ 400 receipt number 0312-9045373), filed by VALEANT PHARMACEUTICALS NORTH AMERICA LLC, KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Civil Cover Sheet, # (10) L. Civ. R. 11.2 Certification)(DENI, WILLIAM) |
| Sep 24, 2018 | 1 | Exhibit A (15) |
| Sep 24, 2018 | 1 | Complaint* (1) |
